Cardiovascular Focused Observational Research
A specialized, scientific approach to cardiovascular real-world evidence — navigating complex patient pathways, treatment patterns, and long-term outcomes.
A Specialized, Scientific Approach to Cardiovascular Real-World Evidence
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality globally, creating a critical need for robust real-world evidence to complement clinical trial data. Observational studies in this space demand a specialized, scientific approach to navigate complex patient pathways, treatment patterns, and long-term outcomes.
At Omega CRO, our team of cardiovascular specialists is highly skilled in the scientific methodology, standard of care, evolving regulatory requirements, and operational considerations necessary to generate the credible RWE needed to support the life-cycle management of cardiovascular therapies and devices. Our extensive experience in cardiovascular studies and relationships with Key Opinion Leaders (KOLs) provide the knowledge and flexibility to adapt to the unique needs of each cardiovascular outcomes study.
The Omega CRO Advantage for Cardiovascular Studies
Global Footprint
A global footprint with strategic medical, regulatory, and operational leadership to deliver high-quality, regulatory-grade insights.
Integrated Data Management
Fully integrated data management and biostatistical services for comprehensive real-world evidence generation.
Proven Epidemiology Experience
A proven track record of successfully managing large-scale, population-based cardiovascular studies.
Key Cardiovascular Studies
Our expertise is demonstrated by a proven track record of successfully managing large-scale, population-based cardiovascular studies.
Turkish Acute Myocardial Infarction Registry (TURKMI Study)
A cornerstone national registry designed to provide up-to-date insights into the characteristics, management, and outcomes of patients with acute MI in Turkey. Conducted across 50 PCI-capable centers with a population-based sampling method, it prospectively enrolled consecutive patients to assess management from symptom onset to hospital discharge, with a 2-year follow-up cohort to evaluate long-term outcomes and guideline implementation.
Hypertension Prevalence Study (PatenT & PatenT2)
Conducted with nearly 5,000 volunteers, these landmark studies were pivotal in determining and re-investigating the prevalence of hypertension in Turkey, providing critical national baseline data.
Hypertension Incidence (HinT)
Built upon the PatenT population, this study focused on calculating the incidence of new-onset hypertension, offering insights into the progression of this major cardiovascular risk factor.
Chronic Heart Failure Prevalence Study (HAPPY)
A crucial investigation into the prevalence and predictors of heart failure within the Turkish population, highlighting the burden of this condition.
Salt Consumption in Turkey (SALTURK)
This influential study examined the direct correlation between salt intake and hypertension. Its findings directly informed and prompted the Turkish Ministry of Health's national initiative to reduce salt content in bread, demonstrating the real-world impact of our research.
Cappadocia Cohort Study
An ongoing cohort study managed to identify chronic disease risk factors, including cardiovascular ailments, in specific regions, providing longitudinal data on disease development.
Cardiovascular RWE Capabilities
Building on this foundational experience, we help our clients effectively plan and conduct cardiovascular studies.
Protocol Design
Designing robust protocols for post-market safety and effectiveness studies.
Registry Management
Efficiently managing large-scale cardiovascular registries that demand rigorous data quality and long-term follow-up.
Data Integration
Seamlessly integrating data from electronic health records (EHR), claims databases, and patient-reported outcomes (PROs).
Endpoint Committees
Providing expert management of Clinical Endpoint Committees (CEC) and Data Safety Monitoring Boards (DSMB).
Application Scenarios in the Omega Ecosystem
How Omega\u2019s integrated ecosystem supports cardiovascular research\u2014from coagulation and lipid panels to long-term biomarker storage.
HelixLab
Cardiac Biomarker Panels
Protocol-driven lipid profiles (LDL, HDL, triglycerides), high-sensitivity troponin, NT-proBNP, CK-MP, and hs-CRP with standardized pre-analytical workflows across all sites.
Omega Genetics
Pharmacogenomic Profiling
CYP2C19 and CYP2D6 genotyping for antiplatelet therapy response prediction; familial hypercholesterolemia (FH) variant screening (LDLR, APOB, PCSK9).
Omega Biorepository
Long-Term Biomarker Storage
Multi-temperature biobanking of serial serum/plasma samples for extended follow-up studies, enabling retrospective biomarker analysis in registry cohorts.
Omega Care
Post-Discharge Home Follow-Up
Home-based blood sampling for INR monitoring in anticoagulation studies and remote collection of patient-reported outcomes after acute cardiac events.
Omega Bio
Standardized Cardiac Assay Kits
Kit-based analytical standardization for cardiac troponin and lipid panel harmonization across multi-center registries with lot-to-lot consistency.
Animal Facility
Preclinical Cardiac Safety
GLP-compliant cardiotoxicity studies (hERG, in vivo telemetry) and atherosclerosis models to support early-stage cardiac drug development before clinical transition.
Ready to Advance Your Cardiovascular Research?
Partner with Omega CRO to generate the real-world evidence that drives cardiovascular innovation.
Talk to Our Experts